Lv21
110 积分 2024-07-15 加入
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
47分钟前
待确认
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
1小时前
已完结
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
6天前
已完结
Optimizing neoadjuvant treatment in HER2-positive breast cancer: the role of HER2, HR, PD-L1 expression and regimen selection
11天前
已完结
Breast Cancer Immunotherapy: A Team Science Approach
1个月前
已完结
CD39 and CD73 Expression in Breast Cancer: CD73 as a Favorable Prognostic Factor in HER2-Positive Tumors
1个月前
已完结
Expression and clinical significance of CD155, FGL1, Galectin-9, and PD‑L1 in breast cancer with neoadjuvant chemotherapy
2个月前
已完结
Abstract 203: Promotion of metastasis of ERBB2-positive breast cancer by mesenchymal stem cells via exosomes-mediated activation of ERBB2/ERBB3→PI3K/Akt singaling pathway
2个月前
已关闭
Global patterns and trends in breast cancer incidence and mortality across 185 countries
3个月前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
3个月前
已完结
皖公网安备34019202002308
